中东和非洲医用酶技术市场预测至 2028 年 - COVID-19 影响和酶类型(消化酶、溶栓酶、水解酶和核酸内切酶)的区域分析;应用(疾病治疗、诊断工具、生物医学研究等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 159    |    Report Code: TIPRE00025044    |    Category: Life Sciences

Middle East and Africa Medical Enzyme Technology Market

市场介绍

酶是植物、动物和微生物的活细胞中产生的蛋白质。所有生物体都需要酶来生长以及产生和利用生命所必需的能量。在活细胞中,酶充当催化剂,加速控制生命过程的化学反应。一百多年来,酶一直是重要的工业产品。然而,潜在的应用范围正在迅速扩大。随着重组 DNA 技术的出现,大量生产以前稀有的酶已成为可能,从而降低了成本。此外,在药品制造中,制造手性纯化合物的愿望正在带来新的机遇。技术进步促进了酶在越来越广泛的工艺条件下的使用。

因此,研究和开发活动的显着增加预计将在未来几年对医用酶技术产生巨大需求,预计这将进一步推动医用酶技术市场。

阿联酋和沙特阿拉伯等国家也登记了大量阳性患者。这些地区的医疗产业正在发展。这些地区国家高度依赖医疗器械和生物制药产品。因此,各国的要求面临着一些挑战。随着 COVID-19 和政府采取行动,某些酶应用(例如药品和清洁剂)的需求可能会增加。医学研究和诊断的增加是酶需求增加的主要因素,因为酶广泛应用于医学和制药工程。该地区的一些公司正在与其他企业合作,将所有设施整合到一个屋檐下,以方便客户。例如,DuBiotech 正在积极与著名大学、专科医院、全球监管机构和其他研究园区建立联系和合作伙伴关系,将 DuBiotech 集团与全球生命科学行业联系起来。 DuBiotech 包括一批生物技术、制药和研究公司,其中包括辉瑞 (Pfizer)、安进 (Amgen)、默克雪兰诺 (Merck Serono) 和健赞 (Genzyme) 等全球领先公司,这符合其成为中东主要生命科学中心的理念。许多中小企业也涉足该市。此类举措将有助于在不久的将来吸引医用酶技术市场。

 

< strong>市场概况和动态

中东和非洲的医用酶技术市场预计将从2021年的1.767亿美元增长到2.452亿美元到 2028 年;预计2021年至2028年复合年增长率为4.8%。研发活动预计将为未来几年全球医用酶技术市场的未来定下基调。在过去的几年中,研究人员越来越关注通过部署医用酶技术来提高用于治疗肥胖、癌症和其他治疗的药物的功效。此外,最近发现的一种新酶有望改进用于治疗这些疾病的药物。在过去的几年中,一些主要针对组蛋白脱乙酰酶 (HDAC) 酶的药物因其在增强癌症治疗耐药性方面的贡献而获得了药物开发商和医疗酶技术市场其他利益相关者的广泛关注。随着研发活动的增加,预计医用酶技术市场在预测期内将出现显着增长。

 

主要市场细分市场

从酶类型来看,水解酶细分市场在2020年中东和非洲医用酶技术市场中占据最大份额。 2020年,治疗领域占据中东和非洲医用酶技术市场最大份额。

 

主要来源和上市公司

准备本中东和非洲医用酶技术市场报告时参考的一些主要一手和二手来源包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Merck Kgaa、Thermo Fisher Scientific Inc.、Novozymes、Takeda Pharmaceutical Company Limited、Agilent Technologies, Inc.、Genzyme Corporation、Asahi Kasei Corporation、Promega Corporation、Cytiva 和 Amano Enzyme Inc.

 

< span>购买报告的理由

  • 了解中东和非洲医用酶技术市场格局并确定细分市场最有可能保证丰厚回报
  • 了解中东和非洲医用酶技术市场不断变化的竞争格局,保持领先地位
  • 有效规划并购和合作伙伴关系通过识别最有希望销售的细分市场,在中东和非洲医疗酶技术市场进行交易
  • 通过对中东和非洲医疗各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策酶技术市场
  • 获取中东和非洲地区2021-2028年各细分市场的市场收入预测

 

中东和非洲医用酶技术市场细分

按酶类型

  • 消化酶
    • L-天冬酰胺酶
    • 乳糖酶
    • 其他
  • 溶栓酶
    • 链激酶
    • 尿激酶
    • 其他
  • 水解酶
    • 透明质酸酶
    • 溶菌酶
    • 其他
  • 核酸内切酶
    • Benzonase
    • 其他

 

按申请

  • 疾病治疗
  • 诊断工具
  • 生物医学研究
  • 其他

 

按国家/地区

  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区

 

提及的公司

  1. Merck Kgaa
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. 武田药品工业株式会社
  5. 安捷伦科技公司
  6. Genzyme Corporation
  7. Asahi Kasei Corporation
  8. Promega Corporation
  9. >
  10. Cytiva
  11. 天野酶公司

 

 

 

Middle East and Africa Medical Enzyme Technology Strategic Insights

Strategic insights for Middle East and Africa Medical Enzyme Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-medical-enzyme-technology-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Medical Enzyme Technology Report Scope

Report Attribute Details
Market size in 2021 US$ 176.7 Million
Market Size by 2028 US$ 245.2 Million
Global CAGR (2021 - 2028) 4.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 酶类型
  • 消化酶
  • 血栓溶解酶
  • 水解酶
  • 核酸内切酶
By 应用
  • 疾病治疗
  • 诊断工具
  • 生物医学研究
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Get more information on this report

    Middle East and Africa Medical Enzyme Technology Regional Insights

    The regional scope of Middle East and Africa Medical Enzyme Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-medical-enzyme-technology-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa Medical Enzyme Technology Market

    1. Merck Kgaa
    2. Thermo Fisher Scientific Inc.
    3. Novozymes
    4. Takeda Pharmaceutical Company Limited
    5. Agilent Technologies, Inc.
    6. Genzyme Corporation
    7. Asahi Kasei Corporation
    8. Promega Corporation
    9. Cytiva
    10. Amano Enzyme Inc.        

     

    Frequently Asked Questions
    How big is the Middle East and Africa Medical Enzyme Technology Market?

    The Middle East and Africa Medical Enzyme Technology Market is valued at US$ 176.7 Million in 2021, it is projected to reach US$ 245.2 Million by 2028.

    What is the CAGR for Middle East and Africa Medical Enzyme Technology Market by (2021 - 2028)?

    As per our report Middle East and Africa Medical Enzyme Technology Market, the market size is valued at US$ 176.7 Million in 2021, projecting it to reach US$ 245.2 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Medical Enzyme Technology Market report typically cover these key segments-

  • 酶类型 (消化酶, 血栓溶解酶, 水解酶, 核酸内切酶)
  • 应用 (疾病治疗, 诊断工具, 生物医学研究)
  • What is the historic period, base year, and forecast period taken for Middle East and Africa Medical Enzyme Technology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Medical Enzyme Technology Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Medical Enzyme Technology Market?

    The Middle East and Africa Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Who should buy this report?

    The Middle East and Africa Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.